EV

Eknath Vitthal Ghodekar

Active Director Director DIN 10143444
DIN 10143444 First appointment May 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Eknath Vitthal Ghodekar

Data last updated:

Eknath Vitthal Ghodekar is a Director at Herz Life Sciences Private Limited (since 2023).

DIN 10143444
Primary Designation Director
First Appointment 01 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Herz Life Sciences Private Limited U46596PN2023PTC220209
Director01 May 20232023Active

Directorship timeline

Open interactive timeline →
Herz Life Sciences Private Limited
Premium access

Shareholding and investment profile for Eknath Vitthal Ghodekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eknath Vitthal Ghodekar

Eknath Vitthal Ghodekar currently holds 1 directorship: Herz Life Sciences Private Limited (Director, since 01 May 2023).

Eknath Vitthal Ghodekar was first appointed on 01 May 2023 as Director at Herz Life Sciences Private Limited.

The current boards of Eknath Vitthal Ghodekar's companies include Mohit Madhav Kumbhar (Herz Life Sciences Private Limited), Rohit Adhikrao Yelave (Herz Life Sciences Private Limited), Sachin Mohan Yadav (Herz Life Sciences Private Limited), Sohal Pendse (Herz Life Sciences Private Limited), Sourabh Sudhakar Ambapkar (Herz Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available